Cited by 35SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesViral Infections and Immunology Research

Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes

Open access
Yang, Jing, Chen, Tan, Zhou, Yafeng·2021·Hereditas

Abstract

Background: The coronavirus disease 2019 (COVID-19) has spread rapidly around the world. In addition to common respiratory symptoms such as cough and fever, some patients also have cardiac injury, however, the mechanism of cardiac injury is not clear. In this study, we analyzed the RNA expression atlases of angiotensin-converting enzyme 2(ACE2), cathepsin B (CTSB) and cathepsin L (CTSL) in the human embryonic heart at single-cell resolution. Results: The results showed that ACE2 was preferentially enriched in cardiomyocytes. Interestingly, serine protease transmembrane serine protease 2 (TMPRSS2) had less expression in cardiomyocytes, but CTSB and CTSL, which belonged to cell protease, could be found to be enriched in cardiomyocytes. The results of enrichment analysis showed that differentially expressed genes (DEGs) in ACE2-positive cardiomyocytes were mainly enriched in the processes of cardiac muscle contraction, regulation of cardiac conduction, mitochondrial respiratory chain, ion channel binding, adrenergic signaling in cardiomyocytes and viral transcription. Conclusions: Our study suggests that both atrial and ventricular cardiomyocytes are potentially susceptible to severe acute respiratory syndrome coronavirus-2(SARS-CoV-2), and SARS-CoV-2 may enter ventricular cardiomyocytes using CTSB/CTSL for S protein priming. This may be the partial cellular mechanism of cardiac injury in patients with COVID-19.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s41065-020-00168-4

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cardiomyocytes and pericytes express ACE2 and TMPRSS2, as well as other accessory proteins needed for viral infection by SARS-CoV-2.

    “Thus, cardiomyocytes and pericytes express ACE2 and TMPRSS2, as well as other accessory proteins (ie, NRP1 [neuropilin-1 receptor], CD147 , integrin α 5 β 1, and cathepsin B/L) needed for viral infection by SARS-CoV-2”

    From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [25]

    The cell-type expression atlas reports ACE2 and cathepsin B/L RNA expression in cardiomyocytes, but little TMPRSS2 expression and no ACE2+/TMPRSS2+ cell cluster. The Discussion says the study analyzed RNA, not protein, expression. Our copy does not report these findings for pericytes or examine NRP1, CD147, or integrin α5β1. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 22 · Cited by 35

Research works printed but not linked: 17

  1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061-9.
  2. Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection. bioRxiv. 2020. https://doi.org/10.1101/2020.02.03.931766. · DOI · Paper page
  3. Babapoor-Farrokhran S, Rasekhi RT, Gill D, Babapoor S, Amanullah A. Arrhythmia in COVID-19. SN Compr Clin Med. 2020. https://doi.org/10.1007/ s42399-020-00454-2. · DOI
  4. Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020;13: 667-73.
  5. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-3.
  6. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271-280.e8.
  7. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4: 44-57.
  8. Goodyer WR, Beyersdorf BM, Paik DT, Tian L, Li G, Buikema JW, et al. Transcriptomic profiling of the developing cardiac conduction system at single-cell resolution. Circ Res. 2019;125:379-97.
  9. Gladka MM, Molenaar B, de Ruiter H, van der Elst S, Tsui H, Versteeg D, et al. Single-cell sequencing of the healthy and diseased heart reveals cytoskeleton-associated protein 4 as a new modulator of fibroblasts activation. Circulation. 2018;138:166-80.
  10. Alhogbani T. Acute myocarditis associated with novel middle east respiratory syndrome coronavirus. Ann Saudi Med. 2016;36:78-80.
  11. Kang Y, Chen T, Mui D, Ferrari V, Jagasia D, Crosbie MS, et al. Cardiovascular manifestations and treatment considerations in COVID-19. Heart. 2020;106: 1132-41.
  12. Burrell LM, Risvanis J, Kubota E, Dean RG, MacDonald PS, Lu S, et al. Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J. 2005;26:369-75.
  13. Goulter AB, Goddard MJ, Allen JC, Clark KL. ACE2 gene expression is up- regulated in the human failing heart. BMC Med. 2004;2:19.
  14. Mehra S, Kumar M, Manchanda M, Singh R, Thakur B, Rani N, et al. Clinical significance of cathepsin L and cathepsin B in dilated cardiomyopathy. Mol Cell Biochem. 2017;428:139-47.
  15. Akhmerov A. Marbán E.COVID-19 and the heart. Circ Res. 2020;126:1443-55.
  16. Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A. Myocardial injury and COVID-19: possible mechanisms. Life Sci. 2020. https://doi.org/10.1016/j.lfs.2020.117723. · DOI
  17. Ma S, Sun S, Li J, Fan Y, Qu J, Sun L, et al. Single-cell transcriptomic atlas of primate cardiopulmonary aging. Cell Res. 2020:1-18. https://doi.org/10.1038/ s41422-020-00412-6. · DOI

Authors
Yang, J., Chen, T., & Zhou, Y.
Affiliations
  • First Affiliated Hospital of Soochow University (CN)
  • Soochow University (CN)
Corresponding author
  • Chen, Tan
  • Zhou, Yafeng
Venue
Hereditas
Published
2021-01-04
Volume
158
Issue
1
Pages
4-4
ISSN
  • 0018-0661 (ISSN-L)
  • 1601-5223
OpenAlex
W3119560279
Cited by
35
References
22
Citations by year
2025: 2 · 2024: 9 · 2023: 8 · 2022: 6 · 2021: 10
FWCI
2.61
Type
journal article
Language
en
Open access
Locations
  • Hereditas (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (81873486)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
Keywords
SARS-CoV-2, COVID-19 pandemic, cardiomyocytes, ACE2, TMPRSS2, cathepsin B, cathepsin L, viral entry, cardiac injury, single-cell RNA sequencing, human embryonic heart, cardiac conduction, mitochondrial respiratory chain, adrenergic signaling
MeSH terms
Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Cathepsin B, Heart, Humans, Serine Endopeptidases, Signal Transduction, Gene Expression Regulation, Developmental, Myocytes, Cardiac, Cathepsin L, Pandemics, Single-Cell Analysis, Gene Ontology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review